Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cerus Corp (CERS)

Cerus Corp (CERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 732,749
  • Shares Outstanding, K 177,421
  • Annual Sales, $ 159,520 K
  • Annual Income, $ -54,380 K
  • 60-Month Beta 1.08
  • Price/Sales 5.42
  • Price/Cash Flow N/A
  • Price/Book 9.58
Trade CERS with:

Options Overview Details

View History
  • Implied Volatility 49.90% ( -7.03%)
  • Historical Volatility 66.35%
  • IV Percentile 25%
  • IV Rank 16.57%
  • IV High 201.02% on 09/14/22
  • IV Low 19.88% on 03/04/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 237
  • Volume Avg (30-Day) 153
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 13,516
  • Open Int (30-Day) 18,074

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.25 +27.08%
on 11/03/22
4.16 -0.72%
on 11/11/22
+0.44 (+11.92%)
since 11/01/22
3-Month
3.25 +27.08%
on 11/03/22
4.32 -4.29%
on 09/12/22
+0.04 (+0.98%)
since 09/01/22
52-Week
3.25 +27.08%
on 11/03/22
7.20 -42.60%
on 12/08/21
-2.58 (-38.45%)
since 12/01/21

Most Recent Stories

More News
Cerus Corporation to Participate in Upcoming Investor Conferences

Cerus Corporation (Nasdaq: CERS) announced today that Vivek Jayaraman, Cerus’ chief operating officer, is scheduled to participate in two conferences:

CERS : 4.13 (+3.25%)
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates

Cerus (CERS) delivered earnings and revenue surprises of 0% and 1.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CERS : 4.13 (+3.25%)
PRGO : 32.14 (-0.28%)
Cerus: Q3 Earnings Snapshot

Cerus: Q3 Earnings Snapshot

CERS : 4.13 (+3.25%)
Cerus Corporation Announces Third Quarter Financial Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the third quarter ended September 30, 2022.

CERS : 4.13 (+3.25%)
Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate

Cerus Corporation (Nasdaq: CERS) today announced that it has been awarded a $9.1 million contract by the U.S. Department of Defense (DoD) Industrial Base Analysis and Sustainment (IBAS) program for the...

CERS : 4.13 (+3.25%)
Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage

Cerus Corporation (Nasdaq:CERS) today announced it has received approval from Health Canada to extend the storage of platelets treated with the INTERCEPT Blood System from five days to seven days from...

CERS : 4.13 (+3.25%)
Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022

Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2022 financial results will be released on Thursday, November 3, 2022, after the close of the stock market. The Company will host...

CERS : 4.13 (+3.25%)
Cerus Corporation Announces Workshop and Abstracts at the 2022 AABB Annual Meeting

Cerus Corporation (Nasdaq:CERS) today announced a selection of abstracts and an industry workshop at the 2022 AABB Annual Meeting, taking place in Orlando, FL from October 1 through October 4. This year’s...

CERS : 4.13 (+3.25%)
After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for Cerus (CERS)

Cerus (CERS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings...

CERS : 4.13 (+3.25%)
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

Sector ETF report for XHE

XHE : 93.60 (+2.14%)
VIVO : 31.99 (-0.03%)
CYRX : 19.88 (+0.66%)
CERS : 4.13 (+3.25%)
IHI : 53.64 (+1.11%)
MDEV : 19.24 (+1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

3rd Resistance Point 4.37
2nd Resistance Point 4.25
1st Resistance Point 4.19
Last Price 4.13
1st Support Level 4.01
2nd Support Level 3.89
3rd Support Level 3.83

See More

52-Week High 7.20
Fibonacci 61.8% 5.69
Fibonacci 50% 5.22
Fibonacci 38.2% 4.76
Last Price 4.13
52-Week Low 3.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar